Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jan 09, 2024

SELL
$128.64 - $184.79 $64,834 - $93,134
-504 Closed
0 $0
Q2 2021

Jan 09, 2024

SELL
$160.2 - $186.42 $13 Million - $15.2 Million
-81,352 Reduced 99.38%
504 $89.5 Million
Q1 2021

Jan 09, 2024

BUY
$150.19 - $173.5 $12.2 Million - $14.1 Million
81,358 Added 16336.95%
81,856 $498,000
Q4 2019

Jan 09, 2024

BUY
$117.65 - $153.73 $58,589 - $76,557
498 New
498 $74.3 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.